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Kidney TransplantationLowering Perfusate Temperature From 37C to
32CDiminishes Function in a PorcineModel of Ex
Vivo Kidney Perfusion
Thomas D. Adams, MBBS, BSc,1 Meeta Patel, MSc,2 Sarah A. Hosgood, PhD,1,2
and Michael L. Nicholson, DSc, FRCS1,2
Background. Ex vivo perfusion (EVP) is a novel method of preservation. However, optimal perfusion conditions remain unde-
termined. Reducing the temperature of the perfusate to subnormothermia may be beneficial during EVP and improve early graft
function. The aim of this study was to investigate whether subnormothermia would influence the conditioning effect of EVP when
compared with normothermic perfusion, and standard cold static storage (CS).Methods.Porcine kidneys underwent static CS
for 23 hours followed by 1 hour of EVP using leukocyte-depleted blood at a mean temperature of 32°C or 37°C. After this, kidneys
were reperfused with whole autologous blood at 37°C for 3 hours to assess renal function and injury. These were comparedwith a
control group that underwent 24 hours CS.Results.During EVP, kidneys perfused at 37°C had a higher level of renal blood flow
and oxygen consumption compared with EVP at 32°C (P = 0.001, 0.002). During reperfusion, 32°C EVP kidneys had lower cre-
atinine clearance and urine output than control (P = 0.023, 0.011) and a higher fractional excretion of sodium, serum potassium,
and serum aspartate transaminase than 37°C EVP kidneys (P = 0.01, 0.023, 0.009). Conclusions. Tubular and renal func-
tions were better preserved by a near-physiological temperature of 37°C during 1 hour of EVP, when compared to EVP
at 32°C or cold storage.
(Transplantation Direct 2017;3: e140; doi: 10.1097/TXD.0000000000000655. Published online 23 February, 2017.)The principle of therapeutic hypothermia—organ protec-tion through induction andmaintenance of a subnormal
core temperature—has seen increasing clinical application.
Considerable evidence exists for a neuroprotective effect after
traumatic brain injury, neonatal hypoxic encephalopathy
and major cardiac ischemia or operations1; accordingly,
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Transplantation DIRECT ■ 2017surgery, and traumatic brain injury now advocate the use of
therapeutic hypothermia ranging from 32°C to 35°C.2-4
It is thought that hypothermia exacts a cytoprotective
effect predominantly against secondary injury, through nu-
merous pathways including: decreased oxidative metabolism
and associated oxidative damage, attenuated proinflamma-
tory mediator release and potency, reduced vascular perme-
ability, and improved cellular integrity.1 Because many of
these protectivemechanisms are highly conserved, it has been
hypothesized that hypothermia may similarly prevent or
abate renal injury. There further have been historical reports
of hypothermia conditioning against ischemia, and to a lesser
extent reperfusion, in a murine model.5
Furthermore, a randomized dual-center study recently
documented a significantly lower incidence of delayed graft
function in recipients receiving kidneys from deceased do-
nors that had been cooled to 34°C to 35°C before retrieval.6
Our group has developed an ex vivo perfusion (EVP) cir-
cuit designed to assess, condition, and treat marginal organs
to improve graft outcomes. The kidney is placed on a modi-
fied pediatric heart-lung bypass circuit where it is perfused
at normal core body temperature with an oxygenated, autol-
ogous blood-based solution. This normothermic EVP circuit
has been used to condition and assess2,7 marginal kidneys
and has the potential to allow targeted drug delivery to the
isolated organ.www.transplantationdirect.com 1
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to 38°C, defined here as near-normothermia, based on fa-
vorable outcomes as compared to cold storage (CS)8; a
comparable system operating at 32°C, defined here as
subnormothermia, has been reported. Brasile et al9,10 have
used this subnormothermic perfusion with an acellular,
oxygen-carrying perfusate to report cytoprotective gene in-
duction and reduced reperfusion injury in a canine model of
donation after cardiac death (DCD) organ retrieval.
The aim of this study was to investigate whether sub-
normothermia would influence the conditioning effect of
EVP, when compared to near-normothermia and standard
static CS.
MATERIALS AND METHODS
This study used a porcine model of controlled DCD
procurement kidneys that underwent a fixed length of warm
ischemia (WI) and CS before undergoing either further CS,
normothermic (EVP 37°C) or subnormothermic (EVP 32°C)
perfusion. They then underwent a period of reperfusion
on the isolated organ perfusion system to assess function
and injury.
Female Landrace pigs weighing approximately 50 kg were
terminated under Schedule 1 of the Home Office Scientific
Act (1986) regulations. After exsanguination and collection
of blood into a sterile receiver containing 25000 units of
heparin the kidneys were exposed to 10 minutes of warm
ischemia before being flushed with 500 ml of Soltran
(hyperosmolar citrate solution, Baxter, UK) at 4°C. Kidneys
were then stored on ice for either 23 or 24 hours in further
Soltran preservation solution.
Kidneys were randomly assigned into 1 of 3 groups
(n = 6 per group), control; 24 hours of static CS, normother-
mic; 23 hours of CS followed by 1 hour EVP at 37.0°C, or
subnormothermic temperature; 23 hours of CS followed by
1 hour EVP at 32.0°C.
Ex Vivo Perfusion
The system was designed using pediatric cardiopulmo-
nary bypass technology (Bioconsole 550, Medtronic,
Watford, UK) as previously described.11 The circuit is
primed with a perfusate solution followed by autologous
whole blood which was depleted of leukocytes using a
white cell filter (LeukoGuard RS; Pall Medical, Portsmouth,
UK) to give a total circulating volume of approximately 1 L.
The perfusate was oxygenated with 95% O2/5% CO2 at
0.2 L/min. The renal artery, vein and ureter were cannulatedTABLE 1.
Infusions and supplements added to the perfusion circuit during
Infusion solution Additives
1000 mL Ringer lactate
(Baxter Healthcare Ltd, UK)
0.116 g Creatinine (Sigma-Aldrich, Ste
5 g Mannitol (Sigma-Aldrich, Steinheim
12 mL Sodium Bicarbonate 8.4%
Dexamethasone 3.3 mg/1 mL
500 mL Synthamin 10%
Amino Acid Infusion (Baxter Healthcare Ltd, UK)
100 IU Insulin
15 mL 8.4% Sodium Bicarbonate
1000 mL glucose 5%
100 mL 0.9% sodium chloride Epoprostenol 10 μgwith soft silastic catheters (Pennine, UK) and kidneys were
flushed with 100 ml of Ringer lactate solution at 4°C immedi-
ately before perfusion to remove the high-potassium preserva-
tion solution. Kidneys were placed in the kidney chamber and
perfused at a mean arterial pressure (MAP) of 75 mm Hg for
1 hour at a normothermic or subnormothermic temperature.
Supplements, detailed in Table 1, were infused into the ve-
nous reservoir and arterial arm of the circuit to provide a pro-
tective environment.Ex Vivo Reperfusion Model
The isolated organ perfusion system was also used to re-
perfuse the kidneys in both groups after the preservation pe-
riod to assess renal function and injury. After 1 hour of EVP
the kidneys were removed from the system and flushed with
100 ml of Ringer lactate solution at 4°C to remove the blood
and cool the kidney.
The reperfusionmodel differs from the normothermic EVP
in that whole autologous blood is used (containing all blood
components) and with certain protective ingredients omitted
(Table 1). The system has no ability to metabolically produce
creatinine, therefore 1000 μmol creatinine (Sigma-Aldrich,
Steinheim, Germany) was added to the circuit so that decre-
ments in serum creatinine and creatinine clearance could be
measured as markers of renal function. Kidneys were placed
on the circuit and reperfused at a near-to-normal12 MAP of
85 mmHg for a period of 3 hours at 38°C. Renal blood flow
(RBF) and MAP were recorded continuously and intrarenal
resistance (IRR) calculated (MAP/RBF). Urine output was
also measured during reperfusion and hourly serum and
urine samples collected. Creatinine clearance ([creatinineurine]
Volurine/[creatinineplasma]) and fractional excretion of sodium
[(Naurine Volurine)/(glomerular filtration rateNaplasma)
100)] were calculated.
Blood gas analysis (Blood Gas Analyser; Rapidlab 248,
Bayer Corp, East Walpole, MA) was used to record arterial
and venous partial pressures of oxygen (PaO2 and PvO2 re-
spectively) carbon dioxide (PaCO2) and acid-base homeosta-
sis. Oxygen consumption [(PaO2 − venous PvO2)  flow
rate/weight] was also calculated.
Cortical wedge biopsies, taken at 3 hours before the end of
the reperfusion, were fixed in 10% formalin before section-
ing and staining with hematoxylin and eosin (H&E). A
blinded observer (TDA) then scored 10 fields per sample un-
der light microscopy at 40magnification for evidence of tu-
bular damage, according to criteria outlined in Table 2.EVP and reperfusion
Duration Infusion rate
inheim, Germany) EVP and reperfusion Priming solution
, Germany) Further Ringer lactate titrated to rate of urine
production to maintain circulating volume
EVP Only
EVP and Reperfusion 20 mL/h
EVP and Reperfusion 5 mL/h
EVP Only 5 mL/h
TABLE 2.
Histological scoring system for assessing tubular injury in
cortical wedge biopsies taken after 3 hours reperfusion
Category
Percentage of field affected
0-24% 25-49% 50-74% ≥75%
Epithelial flattening 0 1 2 3
Tubular dilatation
Vacuolation
Tubular debris
Interstitial edema
Cumulative score 0 - 15
© 2017 Wolters Kluwer Adams et al 3Statistical Analysis
Normally distributed data is presented as mean ± SD and
nonparametric data presented as median (range). Levels of
continuous variables such as RBF were plotted against time
and the area under the curves (AUC) for individual perfusion
experiments were calculated using Excel software (Microsoft,
Reading, UK) and GraphPad Prism version 5.00 forWindows
(GraphPad Software, San Diego, CA, www.graphpad.com).
Mean, AUCand raw valueswere compared using an unpaired
t test with Welch correction (GraphPad Prism).RESULTS
Ex Vivo Perfusion
The temperatures achieved were 37.1 ± 0.4°C in the nor-
mothermic group and 31.0 ± 0.6°C in the subnormothermic
group.
The RBF was significantly higher and IRR lower during
EVP 37°C compared with EVP 32°C (P <0.0001; Table 3,
Figure 1). Oxygen consumption was also significantly higher
in the 37°C group compared with the 32°C group. The
amount of urine produced was numerically higher in the
EVP 37°C kidneys (P = 0.074; Table 3).
Reperfusion
The AUC RBF was significantly higher and IRR signifi-
cantly lower in the EVP 32°C kidneys compared with the
control (P = 0.005, 0.002; Figures 1A and B, respectively).
The level of oxygen consumption was also significantly
higher at 3 hours in the EVP 32°C kidneys compared with
the control (Control 20.8 ± 5.2, EVP 32°C 46.1 ± 15.8,
EVP 37°C 42.6 ± 19.5 mL/min per gram; P = 0.029).
Renal function was significantly improved in the control
and the EVP 37°C groups compared with the EVP 32°C.
The control group produced significantly more urine and
had a higher level of creatinine clearance compared to the
EVP 32°C (P = 0.011; Figure 1D, Table 4), (total urineTABLE 3.
Perfusion parameters during EVP. RBF, IRR, oxygen consumptio
Value Subnormothermic
RBF, mL/min per 100 g 90 ± 23
IRR, mm Hg/mL per min per 100 g 5.12 ± 0.47
Oxygen consumption, mL/min per g 27.5 ± 3.9 53.7 ± 19.0
Urine output (ml) 151 ± 57output; control 467 ± 223, EVP 32°C 168 ± 155 vs EVP
37°C 317 ± 104 mL; P = 0.023). The levels of serum creati-
nine were significantly lower in the EVP 37°C kidneys
(P = 0.026; Figure 1C). The EVP 32°C kidneys had a lower
level of tubular functionwith a significantly higher AUC frac-
tional excretion of sodium compared to the EVP 37°C
(P = 0.001; Figure 1E).
The EVP 37°C kidneys had a significantly lower level of
potassium compared the control (P = 0.023; Figure 1F) and
lower level of aspartate transaminase (AST) compared with
the EVP 32°C (P = 0.009; Figure 1G). Serum levels of lactate
dehydrogenase (LDH)were significantly higher in the control
kidneys compared with the EVP 37°C (P = 0.001;
Figure 1H).
Histology from 3-hour reperfusion biopsies demonstrated
all groups sustained tubular damage, without significant
different between cumulative scores in the control (mean,
7.36; SD, 2.17), EVP 32°C (mean, 7.71; SD, 1.98), and EVP
37°C (mean, 8.34; SD, 2.36) groups. However, there was sig-
nificantly greater epithelial flattening in the EVP 32°C group
versus Control (mean difference, −0.42; P = 0.0075; 1-way
analysis of variance with Holm-Sidak post hoc test) and in-
terstitial edema in the EVP 37°C group compared with EVP
32°C (mean difference, 0.75; P = 0.0002 as above).DISCUSSION
In our model of uncontrolled DCD kidney reperfusion, re-
sults indicate that subnormothermia does not improve the
conditioning effect of EVP upon kidneys subjected to
10 minutes warm and 23 hours cold ischemia, and indeed
may be inferior to CS.
During subnormothermic EVP, kidneys were less well
perfused with significantly higher vascular resistance and
correspondingly lower RBF when compared to kidneys
undergoing normothermic EVP. Thismay reflect themodula-
tory influence of temperature on vascular smooth muscle
contractility.13 The significant reduction in oxygen con-
sumption seen in the subnormothermic group may represent
a reduction in temperature-sensitive adenoside triphosphate–
dependent ion transporter function, and therefore oxidative
metabolism, a mechanism that leads to a well-documented
reversible tubular dysfunction.14-16 The globally high rates
of urine output seen during EVPmay represent a low oncotic
pressure that results from dilution of the red-cell base with
Ringer lactate.
During the reperfusion phase, kidneys from the sub-
normothermic group produced a smaller quantity ofmore di-
lute, natriuretic urine than kidneys from the normothermic
group. These findings, coupled with higher indices of renal
damage (AST and LDH), suggest that upon reperfusion,
subnormothermic kidneys have a higher initial burden ofn, and total urine output
Normothermic P
246 ± 61 <0.0001
2.31 ± 0.54 <0.0001
0.007
245 ± 76 0.074
FIGURE 1. A-H, The AUC (A) RBF, (B) IRR, (C) serum creatinine, (D) creatinine clearance, (E) fractional excretion of sodium, (F) serum potas-
sium, (G) aspartate aminotransferase and (H) LDH, during 3 hours of reperfusion in the Control, EVP 32°C and EVP 38°C groups.
4 Transplantation DIRECT ■ 2017 www.transplantationdirect.comtubular injury. After 3 hours of reperfusion, kidneys from all
groups demonstrated histological evidence of tubular injury.
Higher values for certain indices of injury in subnormothermia
versus control appear to support the poorer creatinine clear-
ance during reperfusion.
Our results would appear to reflect the heterogeneous
clinical literature on whether transplant kidney injury can
be ameliorated by hypothermia. Although Niemann et al6
documented a significantly lower incidence of delayed
graft function in recipients receiving kidneys from deceased
donors that had been cooled to 34°C to 35°C before retrieval,
a correlation between cooling and improvement in donor
renal function was not conclusively shown.
Differences between our subnormothermic perfusion out-
comes and those performed by Brasile et al9,10 may represent
methodological distinctions: whereas we have perfused
porcine kidneys with an autologous red-cell-based perfusate,
Brasile et al perfuse canine kidneys with an acellular fluid; thelonger warm ischemic time favored by Brasile et al, is more
analogous to an uncontrolled, rather than controlled, DCD
retrieval. Despite differences, our studies merit comparison
due to the paucity of data available on this subject.
Two further potential issues related solely to EVP are that
if renal function and proinflammatorymediators are reduced
during hypothermia, this may reduce the capacity of the sys-
tem to deliver targeted drug therapies, and may theoretically
allow propagation of infective organisms present in the
donor kidney.
The advantage of this study is that our model allows us to
interrogate single aspects of physiology in a controlled envi-
ronment that has direct and current clinical application. A
longer reperfusion phase may reveal molecular markers of
kidney injury that would provide a mechanistic foundation
for our findings. A limitation of our study is the absence of
a group of kidneys undergoing hypothermic machine perfu-
sion; without this we cannot definitively characterize the
TABLE 4.
Parameters during ex vivo reperfusion at 1 and 3 hours
Control Subnormothermic Normothermic
1 h 3 h 1 h 3 h 1 h 3 h
CrCL, mL/min per 100 g 2.6 ± 1.3 0.8 ± 0.5 0.5 ± 0.8a 0.2 ± 0.2b 1.9 ± 1.3 1.4 ± 0.6
Fr Ex Na+, % 74 ± 15 55 ± 8 108 ± 19b 69 ± 20b 49 ± 40 31 ± 19
Oxygen Con, mL/min per g 21 ± 6 21 ± 5a 38 ± 14 46 ± 16 36 ± 13 43 ± 20
K+, mmol/L 9.9 ± 1.5c 10.4 ± 1.0 8.1 ± 0.8 8.2 ± 3.6 7.6 ± 1.5 7.9 ± 1.9
AST (mmol/L) 104 ± 17 191 ± 97 223 ± 258 823 ± 412a 90 ± 51 156 ± 50b
LDH, mmol/L 437 ± 83c 487 ± 101 442 ± 125b 833 ± 266b 276 ± 45 320 ± 20
Levels of creatinine clearance (CrCl), fractional excretion of sodium (Fr Ex Na+), oxygen consumption, potassium (K+), AST, LDH.
a Subnormothermic vs control (P <0.05).
b Subnormothermic versus normothermic (P <0.05).
c control versus normothermic (P < 0.05).
© 2017 Wolters Kluwer Adams et al 5influence of temperature over perfusion itself. It would
further be desirable to undertake autotransplant experiments
to confirmour ex vivomeasurementswith those posttransplant.
In conclusion, this study provides evidence that sub-
normothermic EVP of DCD kidneys is inferior to a near-
physiological normothermic perfusion, which better preserved
tubular and renal function.REFERENCES
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